BioAge Labs, Inc. Common Stock

BIOA XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

740M

Short interest (May 15)

3.8%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.46%

↑ 23.9%

Available Shares

↑ 24.7%

Price Chart

Company Overview

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001709941

Asset Type: CS

Market Data

Market Cap: $735,248,220

Employees: 62

Status: Active

Short Interest

Current Borrow Fee 0.46%

Range: 0.45% - 0.46%

Available Shares 1M

Range: 1M - 1M

Recent Changes

Fee Change: ↓ 12.0%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime